Microbiome Therapeutics Market - Global Industry Analysis

Microbiome Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Category: Pharmaceutical Report Format : PDF Report Code: ZMR-2305 Status : Upcoming


Microbiome Therapeutics Market: Overview

The microbiome is a term that is used for the collection of microbes. In the microbiome therapeutics, prebiotics, probiotics, and synbiotics have an influential role in the prevention, diagnosis, and treatment of different types of disease conditions. The factor that favors the microbiome therapeutics is that unlike the drug molecules microbiome therapeutics do not have any side effects since microbiome are already present in the body.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Microbiome Therapeutics Market: Facts

The scientists are making rapid advancements in the study that involves the widespread network of the microbiome and its effect on the human neurology, skin, metabolism, and the immune system. There is evidence that proves that the presence of the dysbiosis in the gut have an effect on an array of conditions such as atopy, cancer, type 2 diabetes, neurological disorders, inflammatory bowel disease, asthma, obesity, and fatty liver disease. The Bristol Myers-Squibb and Enterome entered into the partnership for the development and the discovery of the biomarkers and the microbiome-derived drug targets which will prove useful in the cancer therapeutics.

Microbiome Therapeutics Market: Segmentation

The global market for the microbiome therapeutics is fragmented into its product type, distribution channel, and the application area. On the basis of the product type, the global market is segregated into prebiotics, probiotics, and synbiotics. On the basis of the distribution channel, the market is categorized into drug stores, super and hypermarkets, hospital pharmacies, retail pharmacies, and e-commerce stores. On the basis of the application area, the market is divided into respiratory health, immune conditions, digestive health, oral health, and others.

Microbiome Therapeutics Market: Growth Factors

The primary factors that are driving the microbiome therapeutics market are increase in the problems related to digestion and rise in the drug-related side effects. The therapy can also be used as a treatment for the disease conditions that have no other treatments, as a dietary supplement for improving the overall health, and it is considered as a non-immunogenic as well. The challenges that the market is facing include the high cost of the therapy due to the fact that this therapy is a complex process and needs the extraction of the bacteria in the laboratory. To add on, other factors that restrict the market growth are lack of proper regulations and the microbiomes are heat sensitive.

Microbiome Therapeutics Market: Regional Analysis

The region that is leading in the microbiome therapeutics market is North America which is followed by European regions. The factor that is favoring the growth of the market in the North America is the growing consumption of the dietary supplements. Factor that favors the growth of the market in Europe is the implementation of the less stringent regulations for marketing the probiotic products. In Asia Pacific region, the microbiome therapeutics market is developing at a good pace.

Microbiome Therapeutics Market: Competitive Players

The key market players that are involved in the microbiome therapeutics market include AB-Biotics, AbbVie Inc., Yakult, Ganeden, Pfizer Inc., Johnson and Johnson, Vedanta Biosciences, Dannon, Bayer, Sigma-Tau Pharmaceuticals, and others.

Microbiome Therapeutics Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

Request the coronavirus impact analysis across industries and markets


Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social